None listed
Conditions
Brief summary
International guidelines now recommend screening for primary aldosteronism (PA) in people with chronic hypertension, however this is often not done. Unlike essential hypertension, PA has specific treatments, some of which can even provide a cure. Pregnancy and the postpartum provides a window of opportunity to screen women and improve their longterm health outcomes. However we don't know the prevalence of PA in this population. We aim to determine the prevalence of PA in women who have chronic hypertension after pregnancy. With a pragmatic design, we also aim to provide both quantitative and qualitative data on performing initial screening on medications commonly used in the postpartum period.
Interventions
Women who had hypertension will be followed up postpartum. PA screening is now recommended for all adults with hypertension.
For those with pre-existing chronic hypertension, screening for PA will be performed at 6 weeks postpartum. For those with de novo hypertension, an assessment will be completed at 3 months postpartum to assess whether hypertension has resolved or continued (now meeting criteria for chronic hypertension). If new chronic hypertension is diagnosed then PA screening will be pe
Women who had hypertension will be followed up postpartum. PA screening is now recommended for all adults with hypertension. For those with pre-existing chronic hypertension, screening for PA will be performed at 6 weeks postpartum. For those with de novo hypertension, an assessment will be completed at 3 months postpartum to assess whether hypertension has resolved or continued (now meeting criteria for chronic hypertension). If new chronic hypertension is diagnosed then PA screening will be performed. If screening tests are positive, participants will proceed to confirmatory testing with their local endocrine department.
Sponsors
Eastern Health Clinical School
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Diagnosis of chronic hypertension, gestational hypertension, postpartum hypertension or preeclampsia
Exclusion criteria
Known diagnosis of primary aldosteronism
Outcome results
None listed